Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Psychiatry Updates, 03 Oct 2018

Neuropsychiatric Disease and…